Search

Find out why you still need your routine mammogram, even during COVID-19.

… Wednesday, October 6, 2021 At a time when too many women delayed their yearly mammogram because of the pandemic, Katie Gay is very glad she did not miss hers. She knew that because of her dense breasts, regular screenings were critical. After her routine mammogram in February 2021, Katie found out she

Learn about Madeleine Ruff’s inspiring story, from being treated at MSK Kids for a rare cancer as a teenager to managing clinical trials for new cancer treatments as an adult.

… Monday, June 10, 2024 Madeleine Ruff, MHA, helps manage  clinical trials that test new cancer treatments to see how well they work. It’s an important job but one that doesn’t seem all that unusual, until you learn that Maddy started her career as a professional rock ’n’ roll and jazz singer. It’s certainly

Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.

… Monday, January 30, 2023 Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults. For years, Robin Bankins had chronic sinus pain — one of the effects of Rosai-Dorfman

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.

… Monday, July 15, 2024 There’s a frustrating fact about today’s immunotherapies for cancer . While sometimes they work beautifully — completely eliminating or greatly reducing cancer in particular patients — other times they don’t work at all. It’s a mystery. Scientists have posed several hypotheses to

… Monday, August 4, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: MSK Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care MSK Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology

Immunotherapy drugs called checkpoint inhibitors have been a game changer for some people with cancer. But for most patients, these drugs have been disappointing. Researchers are trying to figure out why.

… Thursday, December 7, 2017 Summary A new analysis finds that certain genes people are born with may play a critical role in whether or not checkpoint inhibitors will work. For some people with cancer, immunotherapy drugs called checkpoint inhibitors , which take the brakes off the immune system and allow

Immunotherapy drugs called checkpoint inhibitors are effective against many cancers, including kidney cancer. Learn how these drugs are used to treat both early- and late-stage disease.

… Monday, September 12, 2022 In an effort to improve the prognosis (outcomes) for kidney cancer , more patients are receiving immunotherapy , which activates the body’s own immune system to kill cancerous cells. Here, genitourinary medical oncologist Robert Motzer from Memorial Sloan Kettering Cancer Center

The third-annual Crain’s New York Business Notable in Healthcare list celebrates outstanding individuals in the healthcare community within the New York metropolitan area, and honors their professional, civic, and philanthropic achievements.

… Monday, August 10, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Physician-in-Chief and Chief Medical Officer Lisa M. DeAngelis, MD , and Community Outreach Manager Julia Ramirez, MA , are included on the Crain’s New York Business 2020 Notable in Healthcare list. The list celebrates outstanding

The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop.

… Tuesday, April 8, 2014 Summary The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop. This image, generated in the lab of molecular biologist Prasad Jallepalli , shows a human cell nucleus — a membrane-enclosed compartment within

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

… Tuesday, December 13, 2011 Summary Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers. A Memorial Sloan Kettering study suggests that in the future, researchers might be able